Simplify Asset Management »

BioMarin Pharmaceutical shares owned by Simplify Asset Management

Quarter-by-quarter ownership of BioMarin Pharmaceutical (BMRN) shares owned by Simplify Asset Management from 13F filings

Historical chart of Simplify Asset Management investment in BioMarin Pharmaceutical

Tip: Access up to 7 years of quarterly data

All positions including BioMarin Pharmaceutical held by Simplify Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in BioMarin Pharmaceutical by Simplify Asset Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $597k 8.5k 70.29
2024-06-30 $417k 5.1k 82.33

More positions owned by Simplify Asset Management

Spdr Gold Tr Gold Shs Put Option (GLD)
Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Core Us Aggbd Et (AGG)
Ishares Tr Iboxx Hi Yd Etf Put Option (HYG)
Simplify Exchange Traded Fun Aggregate Bond E (AGGH)
Simplify Exchange Traded Fun Stable Incm Etf (BUCK)
Simplify Exchange Traded Fun Natl Muni Bd Etf
Simplify Exchange Traded Fun Intmd Term Trsry (TYA)
Simplify Exchange Traded Fun Mbs Etf (MTBA)
Schwab Strategic Tr Us Tips Etf (SCHP)
Simplify Exchange Traded Fun High Yield Plus (CDX)
Pimco Etf Tr Enhan Shrt Ma Ac (MINT)
J P Morgan Exchange Traded F Ultra Shrt Etf (JPST)
Sarepta Therapeutics (SRPT)
Applied Therapeutics (APLT)

View all positions for Simplify Asset Management

Top funds holding BioMarin Pharmaceutical

BlackRock
BlackRock
Vanguard Group
PRIMECAP Management Company
Dodge & Cox
Capital Research Global Investors
Viking Global Investors
State Street Corporation
Elliott Investment Management
Geode Capital Management
Jpmorgan Chase & Co
Bank of New York Mellon
Citadel Advisors
Deutsche Bank Aktiengesellschaft
Northern Trust

View all funds holding BioMarin Pharmaceutical